Trillium Therapeutics Inc. T.TRIL

Healthcare Biotechnology

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.

TSX:TRIL - Post by User

Trillium Therapeutics Inc.

Bullboard Posts

Comment by Jovicaon May 19, 2010 2:09pm

330 Views

Post# 17114472

Level 2 quote

Level 2 Quote

Market Maker	Shares	Bid Price	Ask Price	Shares	Market Maker
--	21,000	0.390	0.400	82,500	--
--	55,500	0.385	0.405	19,000	--
--	78,500	0.380	0.410	30,000	--
--	9,000	0.375	0.415	30,000	--
--	72,000	0.370	0.420	84,500	--
--	5,000	0.365	0.425	67,000	--
--	65,000	0.360	0.430	13,500	--
--	64,000	0.355	0.435	10,000	--
--	163,500	0.350	0.440	67,500	--
--	38,500	0.340	0.450	128,000	--